Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?

Core Viewpoint - NextCure, Inc. (NXTC) has seen a significant stock price increase of 33.9% over the past four weeks, closing at $8.5, with analysts suggesting a potential upside based on price targets, indicating a mean estimate of $17.67, which represents a 107.9% upside potential [1][11]. Price Targets and Analyst Estimates - The mean estimate for NXTC comprises three short-term price targets with a standard deviation of $2.52, where the lowest estimate of $15.00 suggests a 76.5% increase, and the highest estimate of $20.00 indicates a 135.3% increase from the current price [2][9]. - A low standard deviation among price targets suggests a strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9][10]. Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about NXTC's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price movements [11][12]. - The Zacks Consensus Estimate for NXTC's current year has increased by 1.5% over the past month, with no negative revisions, indicating positive sentiment among analysts [12][13]. Zacks Rank and Investment Potential - NXTC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, which further supports the stock's potential upside in the near term [13][14].